India, Feb. 25 -- IAN Alpha Fund, the 2ndin the series of IAN Group's VC funds, along with Speciale Invest, has co-led a Rs 70 crore Series A funding round in Peptris, a Bengaluru-based AI-powered drug discovery startup.

The round also saw participation from Tenacity Ventures, BYT Capital, and other investors. The investment strengthens Peptris' proposition as one of the leading Indian AI drug discovery platforms progressing beyond molecule generation towards clinical-ready assets.

Founded in 2019, Peptris has built an AI-led discovery engine that addresses one of the most persistent problems in healthcare: despite scientific advances, drug discovery remains slow, expensive, and failure-prone, leaving large unmet medical needs. This cha...